VETPLUS

Updated 187 days ago
Private Limited Company
  • Active - 03076466 (CH)
  • Age: 28 years
  • ID: 47004116/24
Dock Road, Lytham, Lancashire, UK FY8 5AQ
• 32990 - Other manufacturing n.e.c.
VetPlus is a family owned business founded in 1995 by David Haythornthwaite in Lytham, Lancashire and is part of the Tangerine Group of companies... A company is only as strong as the people who work together within that organisation. At VetPlus we strive towards building strong management teams and keeping management systems simple. Leading the way through innovation and entrepreneurship is at the heart of VetPlus and are key attributes of everyone who joins us... For over 25 years, VetPlus has pioneered the development and acceptance of nutraceuticals within the UK veterinary profession. We are today a global leader in veterinary nutraceuticals and have distributors in over 30 countries.
Also known as: VET PLUS LIMITED
Registration numbers: 03076466 (CH)
VAT numbers: 534550946
Primary location: Lytham United Kingdom
Associated domains: aktivait.co.uk, aktivait.com, bovimax.co.uk, calmex.co.uk, calmexequine.co.uk, colaid.co.uk, epilease.co.uk, flumax.co.uk, gomegaplus.co.uk, kaminox.co.uk, kaminox.com, laboratoriosvetplus.com, lamaid.co.uk, lypex.co.uk, synequin.co.uk, synequin.com, synoquin.co.uk, synoquingrowth.co.uk, synoquingrowth.com, urinaid.co.uk, urinaid.com, vetplus-int.com, vetplus.fr, vetplus.ie, vetplusasia.com, vetplusglobal.com, vetplusgroup.com, vetplusinc.com, vets-choice.co.uk, vp-inc.us
  • 0
  • 0
Interest Score
3
HIT Score
0.33

UK Company Data

Company number
03076466
Account category
FULL
Account ref. day
30
Account ref. month
6
Accounts next due date
2025-03-31
Accounts last made up date
2023-06-30
Returns next due date
2016-08-03
Returns last made up date
2015-07-06
Num. mort. charges
5
Num. mort. outstanding
2
Num. mort. part. satisfied
0
Num. mort. satisfied
3
Num. gen. partners
0
Num. lim. partners
0
Domain
vetplus.co.uk

Actual
www.vetplus.co.uk

IP
31.22.0.237

Status
OK

Category
Company
0 comments Add a comment